- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03601013
Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Turkey
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Design
The study is a national, multicenter, non-interventional, observational, prospective registry.
Population
Patients older than 18 years old of age, have acute coronary syndrome or percutaneous coronary intervention electively and with available admission hemoglobin, white blood cell and creatine clearance data will be enrolled for Precise-DAPT,and Patients older than 18 years old of age and completed 12 months of dual anti-platelet therapy without having hemorrhage and ischemic coronary event and with available data of age, history of smoking, presence of diabetes mellitus, history of percutaneous coronary intervention, paclitaxel eluting stent, stent diameter, history of myocardial infarction, saphenous vein graft intervention, ejection fraction or presence of heart failure. Patients that do not approve informed consent will be excluded.
Aim
This study is amid to investigate the demographic and clinical profile of patients with CAD and on dual anti-platelet therapy, mean precise -DAPT and DAPT scores of Turkey.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Balikesir, Turkey
- Balikesir University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients that have acute coronary syndrome or percutaneous coronary intervention electively and with available admission heamoglobin, white blood cell and creatine clearance data and on dual antiplatelet therapy
Exclusion Criteria:
- Being under eighteen years old
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ischemia
Time Frame: 3 months
|
ischemic events of patients on dual antiplatelet therapy
|
3 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- DAPT-TR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anti-platelet Therapy
-
Beth Israel Deaconess Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...RecruitingHealthy | Platelet Activation Testing Before/After Anti-platelet TherapyUnited States
-
The First Affiliated Hospital of Dalian Medical...CompletedPercutaneous Coronary Intervention | Aged | Platelet Aggregation Inhibitors | Dual Anti-Platelet TherapyChina
-
University of Roma La SapienzaCompletedDual Anti-platelet TherapyItaly
-
Dallas VA Medical CenterCompletedColonoscopy | Post-polypectomy Bleeding | Anti-platelet TherapyUnited States
-
Ruijin HospitalActive, not recruitingCoronary Artery Bypass | Gastrointestinal Ulcer (Peptic) or Erosion | Anti-Platelet TherapyChina
-
Ascopharm Groupe NovascoGroupe Hospitalier Pitie-Salpetriere; Medco Health Solutions, Inc.CompletedAnti Platelet EffectsFrance
-
Rabin Medical CenterUnknownPlatelet Reactivity | Dual Antiplatelet TherapyIsrael
-
Taipei City HospitalCompletedPRU(Platelet Reactivity Unit) | APT(Antiplatelet Therapy) | HOTPR(High on Treat Platelet Reactivity)Taiwan
-
Charite University, Berlin, GermanyWithdrawnNeed for Renal Replacement Therapy and Anti-infective Therapy Due to Severe InfectionGermany
-
Al-Azhar UniversityEnrolling by invitationEffect of Platelet Rich FibrinDuring Clear Aligner TherapyEgypt
Clinical Trials on Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy
-
Janssen-Cilag, S.A.Completed
-
Xinhua Hospital, Shanghai Jiao Tong University...Recruiting
-
Zhejiang Cancer HospitalRecruiting
-
University Hospital of FerraraCompletedMyocardial Ischemia | Quality of Life | Hemorrhage | Platelet Aggregation InhibitorsItaly
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Centre National...UnknownDiabetes Mellitus | Insulin-DependentFrance
-
Istituto Clinico HumanitasUnknown
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
University Hospital, Basel, SwitzerlandRecruitingAnterior Cruciate Ligament (ACL) InjurySwitzerland
-
University Hospital, MontpellierRecruitingStaphylococcus AureusFrance
-
University Hospital, GenevaSwiss National Science Foundation; University Hospital, BrestCompletedDeep Vein Thrombosis | Pulmonary EmbolismFrance, Switzerland